Effects of major surgery of plasminplasminogen inhibitors.

Although alterations in factors influencing blood coagulation have been extensively studied in various disease states,1,2much less is known about fibrinolysis, the processes by which fibrin deposits and blood clots are dissolved in the living organism.3Evidence is accumulating that the latter is one of the fundamental processes in physiology.3,4In recent years highly purified proteolytic and fibrinolytic enzymes have been used by clinicians in the therapeutic management of thromboembolic disorders.5-8New and more powerful techniques have also become available to study various phases of clot dissolution.9-16These developments have stimulated a growing interest in the fibrinolytic processes and their modifications by disease. Increased fibrinolytic activity has been reported in various pathologic states: conditions of stress, such as acute febrile infections,17electroshock and anoxia,18obstetrical complications, such as premature separation of the placenta,19after pulmonary surgery,4and after extensive carcinoma of

[1]  J. B. Fishman,et al.  Clinical pharmacology of various types of fibrinolytic enzyme preparations , 1960 .

[2]  E. Cliffton Review of clinical experience with clotlysing agents. , 1960, The American journal of cardiology.

[3]  S. Bellet,et al.  Studies of the plasmin-plasminogen system in thromboembolic diseases; its modifications by thrombolysin therapy. , 1960, The American journal of cardiology.

[4]  S. Bellet,et al.  Postoperative changes in blood coagulation in elderly patients. , 1960, The American journal of cardiology.

[5]  A. Fletcher,et al.  The maintenance of a sustained thrombolytic state in man. II. Clinical observations on patients with myocardial infarction and other thromboembolic disorders. , 1959, The Journal of clinical investigation.

[6]  A. Fletcher,et al.  Studies on enhanced fibrinolytic activity in man. , 1959, The Journal of clinical investigation.

[7]  A. Fletcher,et al.  Fibrinolysis and fibrinolytic activity in man. , 1959, Physiological reviews.

[8]  P. Norman,et al.  Studies of the plasmin system. III. Physical properties of the two plasmin inhibitors in plasma. , 1958 .

[9]  M. Lassen The esterase activity of the fibrinolytic system. , 1958, The Biochemical journal.

[10]  P. Norman STUDIES OF THE PLASMIN SYSTEM : II. INHIBITION OF PLASMIN BY SERUM OR PLASMA , 1958 .

[11]  P. Norman Studies of the plasmin system. I. Measurement of human and animal plasminogen; measurement of an activator in human serum. , 1957 .

[12]  I. Innerfield THE ANTI‐INFLAMMATORY EFFECT OF PARENTERALLY ADMINISTERED PROTEASES , 1957, Annals of the New York Academy of Sciences.

[13]  T. Astrup Analytical Review: Fibrinolysis in the Organism , 1956 .

[14]  W. Whitmore,et al.  Hemorrhagic diathesis in patients with carcinoma of prostate. , 1956, Journal of the American Medical Association.

[15]  S. Mullertz Mechanism of activation and effect of plasmin in blood. , 1956, Acta physiologica Scandinavica. Supplementum.

[16]  N. Shulman A proteolytic inhibitor with anticoagulant activity separated from human urine and plasma. , 1955, The Journal of biological chemistry.

[17]  O. Ratnoff,et al.  The multiplicity of plasmin inhibitors in human serum, demonstrated by the effect of primary amino compounds. , 1954, Bulletin of the Johns Hopkins Hospital.

[18]  M. Lassen Heat denaturation of plasminogen in the fibrin plate method. , 1953, Acta physiologica Scandinavica.

[19]  C. C. Roby,et al.  Incoagulable blood in severe premature separation of the placenta: a method of management. , 1953, American journal of obstetrics and gynecology.

[20]  S. Müllertz A plasminogen activator in spontaneously active human blood. , 1953 .

[21]  T. Astrup,et al.  The fibrin plate method for estimating fibrinolytic activity. , 1952, Archives of biochemistry and biophysics.

[22]  N. Shulman STUDIES ON THE INHIBITION OF PROTEOLYTIC ENZYMES BY SERUM , 1952, Journal of Experimental Medicine.

[23]  N. Shulman Studies on the inhibition of proteolytic enzymes by serum. II. Demonstration that separate proteolytic inhibitors exist in serum; their distinctive properties and the specificity of their action. , 1952, The Journal of experimental medicine.

[24]  N. Shulman STUDIES ON THE INHIBITION OF PROTEOLYTIC ENZYMES BY SERUM , 1952, The Journal of experimental medicine.

[25]  Cliffton Ee Variations in the proteolytic and the antiproteolytic reactions of serum: effect of disease, trauma, x-ray, anaphylactic shock, ACTH, and cortisone. , 1952 .

[26]  D. Bifani,et al.  [Postoperative variations of blood coagulation and blood picture]. , 1952, Haematologica.

[27]  N. Shulman,et al.  Proteolytic activity determined with a substrate tagged with radioactive iodine. , 1950, The Journal of biological chemistry.

[28]  D. Grob Proteolytic enzymes; further studies on protein, polypeptide, and other inhibitors of serum proteinase, leucoproteinase, trypsin, and papain. , 1949, The Journal of general physiology.

[29]  N. Fowler,et al.  A STUDY OF CERTAIN ASPECTS OF BLOOD COAGULATION IN THE POSTOPERATIVE STATE IN CONGESTIVE HEART FAILURE AND IN THROMBOPHLEBITIS. , 1949, The Journal of clinical investigation.

[30]  R. Od Studies on a proteolytic enzyme in human plasma; the rate of lysis of plasma clots in normal and diseased individuals, with particular reference to hepatic diseases. , 1949 .

[31]  Sturgis Cc,et al.  Hemorrhagic disorders. , 1954, Postgraduate medicine.

[32]  C. Macleod,et al.  A PROTEOLYTIC ENZYME OF SERUM: CHARACTERIZATION, ACTIVATION, AND REACTION WITH INHIBITORS , 1945, The Journal of general physiology.

[33]  J. Jobling,et al.  THE NATURE OF SERUM ANTITRYPSIN : STUDIES ON FERMENT ACTION. XIII. , 1914 .

[34]  E. Opie,et al.  CHANGES IN THE PROTEOLYTIC ENZYMES AND ANTI-ENZYMES OF THE BLOOD SERUM PRODUCED BY SUBSTANCES (CHLOROFORM AND PHOSPHORUS) WHICH CAUSE DEGENERATIVE CHANGES IN THE LIVER , 1911, The Journal of experimental medicine.

[35]  J. Mellanby The coagulation of blood , 1908, The Journal of physiology.